Your browser doesn't support javascript.
loading
Summary of the WHO hearing on the development of product-specific reference materials for coagulation factor VIII and factor IX products.
Ovanesov, Mikhail V; Williams, Stella C; Nübling, C Micha; Dodt, Johannes; Hilger, Anneliese; Maryuningsih, Yuyun; Gray, Elaine.
  • Ovanesov MV; Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA. Electronic address: mikhail.ovanesov@fda.hhs.gov.
  • Williams SC; Haemostasis Section, The National Institute for Biological Standards and Control, Potters Bar, EN6 3QG, UK. Electronic address: Stella.Williams@nibsc.org.
  • Nübling CM; Paul-Ehrlich-Institute, Langen, 63225, Germany. Electronic address: Micha.Nuebling@pei.de.
  • Dodt J; Paul-Ehrlich-Institute, Langen, 63225, Germany. Electronic address: johannes.dodt@t-online.de.
  • Hilger A; Paul-Ehrlich-Institute, Langen, 63225, Germany. Electronic address: Anneliese.Hilger@pei.de.
  • Maryuningsih Y; Health Products Policy and Standard Department, WHO, Geneva, 1211, Switzerland. Electronic address: maryuningsihy@who.int.
  • Gray E; Haemostasis Section, The National Institute for Biological Standards and Control, Potters Bar, EN6 3QG, UK. Electronic address: Elaine.Gray@nibsc.org.
Biologicals ; 67: 88-93, 2020 Sep.
Article en En | MEDLINE | ID: mdl-32847723
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteínas Recombinantes / Factor IX / Factor VIII Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteínas Recombinantes / Factor IX / Factor VIII Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article